Sublingual Immunotherapy Product
Oraltek is a European-developed sublingual immunotherapy (SLIT) product offering a needle-free option for the treatment of environmental allergens such as cat, dog, grass, and dust mites. It is designed for home use following an initial supervised dose in clinic, providing convenience while maintaining clinical oversight.
Overview
Oraltek supports both single-allergen and multi-allergen therapy, allowing clinicians to tailor treatment to the patient’s sensitisation profile.
This flexibility makes it suitable for patients who prefer a less invasive, home-based approach to immunotherapy.
Safety Profile
Oraltek has a favourable safety profile, with the most common side effects being local and mild, such as:
Common side effects include:
Oral or throat itching or discomfort
Mild swelling under the tongue
Temporary irritation or tingling sensations
Effectiveness
Clinical studies indicate that Oraltek can significantly improve allergic symptoms and reduce reliance on medications over a standard 3–5 year treatment course.
Benefits may take several months to become apparent, with consistent daily use critical to achieving the desired effect.
3–5 year treatment course
Treatment options
Single allergen therapy
Single allergen therapy:
Focused on one allergen for targeted desensitisation.
Multi-allergen therapy
Multi-allergen therapy:
Allows treatment of patients with multiple sensitisations in a single regimen, maintaining a good safety profile.
Both TGA-registered and non-registered options exist.
Clinics must inform patients that all options are privately funded in Australia, with total treatment costs varying from several hundred to several thousand dollars per year.
Initial dose administered under clinic supervision
Daily home administration by placing drops or tablets under the tongue
Consistency in daily dosing is essential
Side effects monitored; contact clinic if severe reactions occur
Patient Suitability
Oraltek may be appropriate for patients who:
Prefer a home-based, needle-free immunotherapy option
Are sensitised to one or multiple environmental allergens
Can commit to daily dosing and follow-up appointments
Are motivated to adhere to treatment schedules for effective desensitisation
Australian Context
Not PBS-subsidised; treatment is privately funded
Conclusion
Oraltek offers a safe, flexible, and convenient SLIT solution for patients with environmental allergies.
Its ability to accommodate multiple allergens in a home-based format makes it particularly suitable for patients seeking a needle-free alternative to SCIT.
Daily adherence and specialist supervision are key to achieving optimal outcomes.
